It is not objectively good news, but Rocket Lab found a defect before risking catastrophic failure on the launchpad.

Rocket Lab’s reported decline from $151 in May to $54.73 on October 30 raises questions about the valuation of its expanding ...

Rocket Lab is keeping us waiting for Neutron.

Rocket Lab Corporation remains a buy despite an expected nearly one-year Neutron rocket delay and increased perceived risk.

Could two numbers in the space company's next report make its 61% drop a buying opportunity?

Rocket Lab heads into its third-quarter report with a striking disconnect. The business keeps setting records, the backlog keeps climbing, and management sounded more expansive last quarter than at ...

Rocket Lab faces a major setback as its much-awaited Neutron rocket launch is delayed to 2027. I rate RKLB stock as Sell.

Rocket Lab's Neutron rocket just slipped past a key deadline, and Wall Street is starting to reprice how long investors will wait for the launch revenue that underpins the entire bull case.

Rocket Lab has posted big revenue growth, but its stock has still seen a huge pullback.

Rocket Lab delays the Neutron rocket's first launch to 2027 after carbon fiber tank dome defects, highlighting manufacturing ...

Rocket Lab has an established launch business, though its price-to-sales ratio of about 45 reflects high growth expectations.